| 崔清昱 王静 秦万民 刘世海 冯玉洁 孙传东.腺病毒携带IL-12增强抗原致敏树突细胞在肝癌基因治疗中的研究[J].,2014,14(31):6125-6128 |
| 腺病毒携带IL-12增强抗原致敏树突细胞在肝癌基因治疗中的研究 |
| Adenovirus Mediated Interleukin-12 Enhances the Gene Therapy ofHepatocarcinoma by Tumor Antigen Plused Dendritic Cells |
| |
| DOI： |
| 中文关键词: 腺病毒 IL-12 肝癌 树突细胞 |
| 英文关键词: Adenovirus IL-12 Hepatocarcinoma Dendritic cells |
| 基金项目:东省2012 科学技术发展计划（2012G0021845）；山东省自然科学基金项目（2011ZRB01588） |
|
| 摘要点击次数: 572 |
| 全文下载次数: 760 |
| 中文摘要: |
| 目的：近年来通过应用白介素-12 治疗肿瘤取得良好效果，因此对国内外应用腺病毒携带IL-12 增强抗原致敏树突细胞在
肝癌基因治疗中的研究进展进行总结，以探索更为可行治疗方法。方法：运用Pubmed、Elsevier Sciencedirect、CNKI及万方全文数
据库检索系统，以腺病毒，IL-12，肝癌，树突细胞为关键词，检索2008-01至2012-11 月发表的文献。纳入标准：1）IL-12 的生物学特
性，在抗肿瘤过程中的免疫作用，2）应用腺病毒携带IL-12 对抗肝癌治疗研究，3）肿瘤抗原致敏树突细胞对肿瘤的影响。根据纳入
标准分析文献26 篇。结果：通过腺病毒携带IL-12 可以增强肿瘤抗原致敏树突细胞的免疫应答。并通过诱导肿瘤细胞的凋亡，减
少新生血管的生成而对肿瘤产生直接抑制，有效抑制肝癌的生长和转移。结论：本文通过对IL-12 的生物学特征、抗肿瘤通路、作
用机制及在腺病毒介导下肿瘤抗原致敏树突细胞研究进展的概述，为腺病毒携带IL-12 作为肝癌的基因治疗进一步提供理论依
据和探索，期待在将来应用IL-12 为基础的基因治疗一定会为包括肝癌在内的肿瘤治疗提供新的途径。 |
| 英文摘要: |
| Objective:Recently, wonderful effect has been achieved on treating tumor by using IL-12. So we summarize the
advances of adnovirus mediated interleukin-12 enhances the gene therapy of hepatocarcinoma by tumor plused dendritic cells at home
and abroad on the purpose of finding a feasible way for treating tumors.Methods:Using adenovirus IL-12,hepatocarcinoma and dendritic
cells as key words, the articles published from the database such as Pubmed. Elsevier Sciencedirect, CNKI and Wanfang, particularly
from January 2008 to November 2011, were searched. Inclusion criteria: 1)the biologic character of IL-12 and the immune effect on the
progress of anti-tumor, 2)the reserch of using adenovirus mediated IL-12 to therapy tumor, 3)The influnce of tumor antigen pulsed
dendritic cell on tumor. Twenty-six articles were selected into analysis according to inclusion criteria.Results:The immune response can
be improved by using adenovirus mediated IL-12 enhances tumor antigen pulsed dendritic cells. Tumors were depressed directly by
inducing the tumor's apoptosis and reducing the angiogenesis, which can depress the growth and metastasis of the hepatocarcinoma
effectively.Conclusion:This article conclude the biologic character, the pathway and mechanismof anti-tumor of IL-12 and the advance
of the stdudy of adenovirus meditated tumor antigen pulsed dendritic cells, which also can provide the theoretical evidence for further
exploration of the hepatocarcinoma gene therapy by adenovirus mediated IL-12. And we hope to provide a novel approach for the tumor
treating including hepatocarcinoma, on the basis of gene cure of IL-12 in the future. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
